CN104435730A - Externally applied traditional Chinese medicine ointment for treating skin ulcer - Google Patents

Externally applied traditional Chinese medicine ointment for treating skin ulcer Download PDF

Info

Publication number
CN104435730A
CN104435730A CN201410664672.2A CN201410664672A CN104435730A CN 104435730 A CN104435730 A CN 104435730A CN 201410664672 A CN201410664672 A CN 201410664672A CN 104435730 A CN104435730 A CN 104435730A
Authority
CN
China
Prior art keywords
radix
skin
ointment
rhizoma
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410664672.2A
Other languages
Chinese (zh)
Other versions
CN104435730B (en
Inventor
向小明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410664672.2A priority Critical patent/CN104435730B/en
Publication of CN104435730A publication Critical patent/CN104435730A/en
Application granted granted Critical
Publication of CN104435730B publication Critical patent/CN104435730B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11Pteridophyta or Filicophyta (ferns)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708Rheum (rhubarb)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/74Rubiaceae (Madder family)
    • A61K36/744Gardenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/758Zanthoxylum, e.g. pricklyash
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/898Orchidaceae (Orchid family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses an externally applied traditional Chinese medicine ointment for treating skin ulcer. The ointment is prepared from astragalus membranaceus, angelica sinensis, cortex phellodendri, scutellaria baicalensis, rheum officinale, shinyleaf pricklyash root, rhizoma paridis, cape jasmine, bletilla striata, ramie root, elephant hide, selaginella tamariscina, borneol, beewax, rapeseed oil, stearic acid, glycerinum, glycerin monostearate, cetanol, potassium hydroxide, ethylparaben and distilled water. The invention further provides a method for preparing the novel ointment for treating skin ulcer. The ointment has the effects of clearing heat, removing toxicity, removing necrotic tissue, promoting granulation, eliminating stasis to subdue swelling, promoting blood circulation, astringing, nourishing skin, relieving pain, reducing wound exudation, quickly repairing wound, relieving scar growth and the like, has the advantages of reasonable formula, simple preparation, proper price and remarkable curative effect, and is convenient to apply.

Description

A kind of external application Chinese medicine ointment for the treatment of sores ulceration of skin
Technical field
The invention belongs to technical field of Chinese medicines, particularly relate to a kind of external application Chinese medicine ointment for the treatment of sores ulceration of skin.
Background technology
Motherland's medical science calls infections section burn skin infection, external injury and the evil infective agent of poison are the principal elements causing creating infections, as: chemical substance, electrical equipment, high light, firearm, bullet, the blasts etc. such as flame, boiling water, steam, molten steel and acid, alkali, phosphorus, phenol all can cause skin injury.The skin hypersensitivity damage that insect and animal biting, cold injury, dermatitis rhus, various animals and plants toxin, lonizing radiation, medicine and a variety of causes cause also belongs to this category.According to the neodoxy of professor Xu Rongxiang to burn theory, this subject can be summarized and be divided into following a few class: 1. hot injury's class, comprises burn and scald, chemical burn, electric burn, electric burn; 2. wound class, as the damage of skin ulceration, knife injury; 3. to burst sick class, comprise the infection of burn and scald and wound and wound surface and burst sick, the infection that dermatosis causes and ulcer, and the traumatic infection caused by inside and outside, woman, youngster, face Deng Ge section disease and ulcer.
The burns unit treatment technology that motherland's medical science is carried out is except the moistening burn exposure method of the auspicious MEIBAO of Xu Rong, great majority mainly allow burn wound keep dry, prevent bacterial invasion from infecting, its deep burn wound electricity consumption baking, makes the rear implementation of local necrosis tissue drying incrustation cut crust and skin grafting is treated.Western medicine is also in surgery's treatment stage of stagnation to burn, wound and ulcer treatment.Therefore, to lose some benefits from modern medicine to make burn patient and cut crust, the medical expenses of the misery that the operations such as skin-grafting bring and great number, invention one has that reducing swelling and alleviating pain is fast, short treating period, wound healing fast, no pain of changing dressings, either shallow do not stay scar, the degree of depth such as not to be made skin graft at the Chinese medicine preparation of magical curative effect, significant.
Summary of the invention
Object of the present invention is exactly for above-mentioned treatment Problems existing, a kind of heat-clearing and toxic substances removing, removing the necrotic tissue and promoting granulation, dissipating blood stasis for subsidence of swelling, putrefaction removing and tissue regeneration promoting are provided, convergence of invigorating blood circulation, skin moistening pain relieving, reduce wound surface ooze out, rapid wound repairing, the external application Chinese medicine ointment of the effects such as lessen scar formation growth, be adapted to the treatment of various burn, wound, skin ulcer, this medicine makes simple, moderate, evident in efficacy, application is convenient.
This ointment is that inventor adopts surgery of Chinese medicine skin infection theoretical basis, the handed down from the older generations of the family and modern burn medical technologies marrow in conjunction with the successive dynasties, the accumulation through being devoted for years to for many years in the academic thought of Ulcerated Burn Wounds Treated treatment and clinical research and unique therapy of drawing.In side, Radix Et Rhizoma Rhei, Radix Scutellariae, Rhizoma Paridis, Fructus Gardeniae, Cortex Phellodendri, Radix Zanthoxyli, Herba Selaginellae have heat-clearing and toxic substances removing, and detumescence is invigorated blood circulation, effect of analgesic and scar eliminating.According to modern pharmacological research and my clinical observation for many years, find that above medicine has stronger anti Bacillus pyocyaneu Flugge, staphylococcus aureus, pyococcus, multiple Gram-negative to local challenge pyemia infection of burning, positive bacteria has obviously suppression to kill and the preventive and therapeutic effect such as stronger removing toxic substances infection and the growth of prevention lessen scar formation; In side, the Radix Astragali, Radix Angelicae Sinensis, the Pseudobulbus Bletillae (Rhizoma Bletillae), Corium elephatis, Borneolum Syntheticum, Cera Flava, Oleum Brassicae campestris have the effect that the ulcer such as benefiting qi and nourishing blood, skin moistening putrefaction removing, expelling pus and promoting granulation pain relieving do not close up for a long time altogether; The present invention is a kind of ointment, and it can be protected skin wound, regulate transepidermal water unlikely drying, thus in this ointment with traditional Chinese herb medicine compatibility; can make that wound surface is changed dressings, medicine carrying non-greasy, skin of cannot not changing dressings stickyly, sticky clothing; change dressings without pain, few hemorrhage, without advantages such as remaining medicine crusts.
The present invention is made up by weight ratio of following traditional Chinese medicines: Radix Astragali 450-550g, Radix Angelicae Sinensis 400-600g, Cortex Phellodendri 400-600g, Radix Scutellariae 450-550g, Radix Et Rhizoma Rhei 450-550g, Radix Zanthoxyli 350-550g, Rhizoma Paridis 400-600g, Fructus Gardeniae 480-600g, Pseudobulbus Bletillae (Rhizoma Bletillae) 450-600g, Radix Boehmeriae 450-550g, Corium elephatis 100-300g, Herba Selaginellae 400-600g, Borneolum Syntheticum 25-30g, Cera Flava 250-400g, Oleum Brassicae campestris 2000-3000g, stearic acid 450-550g, glycerol 450-550g, glyceryl monostearate 50-100g, hexadecanol 100-200g, potassium hydroxide 45-55g, ethyl hydroxybenzoate 20-30g, distilled water 3700-3800g.
Optimum weight proportion: Radix Astragali 500g, Radix Angelicae Sinensis 500g, Cortex Phellodendri 500g, Radix Scutellariae 500g, Radix Et Rhizoma Rhei 500g, Radix Zanthoxyli 500g, Rhizoma Paridis 500g, Fructus Gardeniae 500g, Pseudobulbus Bletillae (Rhizoma Bletillae) 500g, Radix Boehmeriae 500g, Corium elephatis 200g, Herba Selaginellae 500g, Borneolum Syntheticum 20g, Cera Flava 350g, Oleum Brassicae campestris 2500g, stearic acid 500g, glycerol 500g, glyceryl monostearate 75g, hexadecanol 150g, potassium hydroxide 50g, ethyl hydroxybenzoate 25g, distilled water 3750g.
Detailed description of the invention is as follows:
(1) take each weight portion: Radix Astragali 500g, Radix Angelicae Sinensis 500g, Cortex Phellodendri 500g, Radix Scutellariae 500g, Radix Et Rhizoma Rhei 500g, Radix Zanthoxyli 500g, Rhizoma Paridis 500g, Fructus Gardeniae 500g, Pseudobulbus Bletillae (Rhizoma Bletillae) 500g, Radix Boehmeriae 500g, Corium elephatis 200g, Herba Selaginellae 500g, Borneolum Syntheticum 20g, Cera Flava 350g, Oleum Brassicae campestris 2500g, stearic acid 500g, glycerol 500g, glyceryl monostearate 75g, hexadecanol 150g, potassium hydroxide 50g, ethyl hydroxybenzoate 25g, distilled water 3750g.
(2) above-mentioned stearic acid, glycerol, glyceryl monostearate, hexadecanol is got in beaker, heating in water bath to 90 DEG C makes material melting, is uniformly dissolved as oil phase, then potassium hydroxide, ethyl hydroxybenzoate being added in distilled water water dissolves as aqueous phase, under stirring at 90 DEG C, aqueous phase is slowly added oil phase, high-speed stirred carries out emulsion reaction 20min, and being cooled to room temperature, to obtain emulsifying agent for subsequent use.
(3) get the above-mentioned Radix Astragali, Radix Angelicae Sinensis, Cortex Phellodendri, Radix Scutellariae, Radix Et Rhizoma Rhei, Radix Zanthoxyli, Rhizoma Paridis, Fructus Gardeniae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Boehmeriae, Corium elephatis, Herba Selaginellae clear water soak, after decoction, enter Oleum Brassicae campestris, then torture to the dried-up Huang of medicine with slow fire and float filtration of removing slag.
(4) concentrated medicament of filtration and Borneolum Syntheticum, Cera Flava and emulsifying agent obtained above are dissolved and move back to foam clean from fire, form semi-solid mixed type ointment after condensation, basin bottling is for subsequent use.
All medicines are prepared into ointment above, have heat-clearing and toxic substances removing, removing the necrotic tissue and promoting granulation, dissipating blood stasis for subsidence of swelling, putrefaction removing and tissue regeneration promoting, convergence of invigorating blood circulation, skin moistening pain relieving, reduce wound surface ooze out, rapid wound repairing, the effects such as lessen scar formation growth.
The present invention has the following advantages:
(1) the present invention is pure Chinese medicinal preparation, and each component meets the regulation of Pharmacopoeia of People's Republic of China, little to human body toxic and side effects, reliably comparatively safe.
(2) toxin that the present invention can make burn slough degenerate separation and alluvial is drained, and newborn cell tissue can be made to grow fast and accelerate wound healing, shorten treatment time.
(3) the present invention makes wound surface blood transport by drug effect and circulation improves, and makes to ooze out minimizing, and can effectively suppress, kill bacteria makes inflammation prompt resolution.
(4) the present invention is adapted to the treatment of various burn, wound, skin ulcer, makes simple, moderate, evident in efficacy, the features such as application is convenient.
Below by way of clinical observation experiment, set forth beneficial effect of the present invention further
1, patient profiles
The chronic ulcer of skin patient that my Out-patient Department is medical, MethodsThe cases enrolled 140 example, male 74 example, women 66 example, injured reason: wound 28 example, burn 35 example, furuncle, abscess ulceration 26 example, diabetic gangrene 33 example, varicose veins of the lower extremity 8 example, ulcer 10 example caused by hemangioma injection treatment.
2, patient selection's standard
1. meet 140 routine chronic ulcer of skin patients of MethodsThe cases enrolled condition, the course of disease is more than 3 weeks.2. patient temperature is normal, hemogram in normal range, stable disease, and the medication of same disease whole body therapeutic is identical.3. agree to through sufferers themselves and can adhere to continuing dressing change at the court's dressing room.
3, Therapeutic Method
140 routine patients are divided into treatment group and each 70 examples of matched group at random, and the age of two groups of patients, injured reason, ulcer level, area and time there was no significant difference, have comparability.Treatment group patient is first with 0.9% sodium chloride solution cleaning or iodophor disinfection wound surface, and its absorbed themselves treated by vesicle, and large blister oozes out the capable low level of after date at blister to be cut off tapping and retains bubble skin.Patients with deep burn should remove beancurd sheet and slough as early as possible in the tissue rotten de-liquefaction phase.Do not need anesthesia in debridement process, strictly follow noinvasive cleaning principle, then faster for skin infection of the present invention cream spatula is applied to wound surface and adopts and to expose or gauze such as to be applied ointment or plaster at the occlusive dressing, change dressings every day once, until wound healing.Matched group only changes faster for the skin infection being applied to ulcer wound surface cream into moist expose burn ointment, and all the other are identical with treatment group.
4, curative effect judging standard
Treatment group and matched group all do Statistical Comparison evaluation after dressing change 30d.Total obvious effective rate is that healing adds effective percentage.
Cure: symptom, sign all disappear, functional activity recovers normal, wound healing.
Effective: symptom, sign are clearly better, and wound surface obviously reduces, yellowish pink turn red, and pus tails off.
Invalid: skin surface symptom without improvement, or have increase the weight of tendency.
5, therapeutic outcome
In the routine sores ulceration of skin patient for the treatment of group 70, cure 59 examples, cure rate 84.28%, effective 7 examples, total obvious effective rate 94.29%, invalid 4 examples, inefficiency 5.71%.In the routine sores ulceration of skin patient of matched group group 70, cure 36 examples, cure rate 51.43%, effective 16 examples, total obvious effective rate 72.29%, invalid 18 examples, inefficiency 25.71%.
Above clinical practice proves that this ointment is in burn wound's treatment, intuitively can understand wound surface clinical healing process, can effectively by drug osmotic subcutaneous tissue; Dirt, the bacteriotoxin that can effectively purify between wound surface and tissue comes off with being separated of slough; Effectively can improve local circulation, stop the stagnant impaired local organization necrosis progrediens of the stasis of blood, infection control, make the normal structure invasion and attack of burn slough not under wound surface; And effectively can promote the Regeneration and Repair of wound surface damaged tissues.In the de-liquefaction eliminating of deep wounds slough corruption and growth course; because this ointment effect is unique; when the most flesh level flesh shoot regeneration of wound tissue corruption; granulation surface can form one deck white or faint yellow gluey protecting film, and this tunic is the feature proving that burn wound's skin physiology regeneration and tissue growth are repaired.To dark two degree, 3-degree wound can remove rapidly separation slough.As dark two degree of wound surface 4 ~ 5 days downright bad layers start the liquefaction that comes off, within about 10 days, liquefaction is made to be in peak, within about 15 days, wound surface basilar part skin island is organized raised, the granulation tissue of about 20 days projections becomes calms down, and the epithelial tissue of visible white is closed to four perithelium island spreading via tissue spaces and reaches healing centered by hair bladder.As 3-degree wound can be shown in that wound surface has liquefied substance for 3 ~ 7 days, slough generally takes off sanies in 2-3 week to be terminated.Substrate about 15 days gradually to rat in " granulation ", part granulation, while epithelial edge spreads, wound surface is dispersed in skin point and spreads gradually, mutually merges and closes and form wound healing.
Below by way of irritation test, observe the present invention further to the zest of skin
1, experimental animal
Get 8 healthy white rabbit, female half and half, by lateral symmetry region, back unhairing 150cm 2sub-cage rearing, observes 24h.Be divided into two large groups at random, first group of intact skin group, second group of damaged skin group (hair-fields sterilization skin of respectively running away like a hare being drawn homalographic # word, the degree of being with oozing of blood, as damaged skin group with scalpel).
2, test method
Adopt consubstantiality left and right sides own control, the left dorsal often organizing rabbit is coated with the faster cream 1ml of skin infection of the present invention, and the right side back of the body is coated with moist expose burn ointment 1ml, administration every day 1 time, continuous 7d, each remove medicine after 1h and observing before again sticking and situation such as record erythema and edema etc.After last sticks, 1h, 24h, 48h and 72h perusal after removal medicine also records coating part with or without the situation such as erythema and edema.
3, result of the test
The faster cream group of skin infection of the present invention and the continuous 7d of moist expose burn ointment matched group give the complete of rabbit and damaged skin, all do not find obvious erythema and edema reaction, Continuous Observation 10d, each rabbit skin health, vacuum response occurs, and shows that the faster cream of skin infection of the present invention all has no stimulation to the complete of rabbit and damaged skin.
Toxicity profile of the present invention is observed further below by way of skin sensibiligen test
1, experimental animal
Get 12 healthy white rabbit, female half and half, by lateral symmetry region, back unhairing 150cm2 sub-cage rearing, observe 24h.
2, test method
Above-mentioned rabbit is divided into three groups, first group of intact skin group by study of tcm new drug guide (pharmacy, pharmacology, toxicology) at random that issue with reference to bureau of drug administration of Ministry of Health of the People's Republic of China, gives the faster cream clinical equivalent of skin infection 4 times of concentration; Second group of damaged skin group (hair-fields sterilization skin of respectively running away like a hare being drawn homalographic # word, the degree of being with oozing of blood, as damaged skin group with scalpel), gives the faster cream clinical equivalent of skin infection 4 times of concentration; 3rd group of matched group, gives moist expose burn ointment.Dosage is 2ml/ time, in 24h, interval administration amounts to 3 times, depilation district, left side is evenly applied to by reagent, give by after reagent 24h, wash away residue, and in 1,24,48,72h to d7, the situation of the systems such as the change of each rabbit body weight of observed and recorded every day, skin and hair, eye and mucosa and breathing, central nervous system, quadruped locomotion.
3, result of the test
Administration 1h, observes the skin of each treated animal, hair, mucosa after 24h, 48h, 72h to 7d, breathe, circulation, nervous system, and extremity activity etc. is showed no ANOMALOUS VARIATIONS, and be poisoned to death without animal, damaged skin group also has no obvious inflammatory reaction and performance of suppurating.Before following table 1 observes administration and after administration 7d, each group rabbit body weight change no significant difference.
The faster cream of table 1 skin infection is on the impact of the acute toxicity test body weight of rabbit skin
Result of the test shows, the faster cream high dose group of skin infection and moist expose burn ointment matched group respectively observe 7d to intact skin and damaged skin rabbit, does not occur any acute toxic reaction (P > 0.05).
The sensitivity of the present invention to skin is observed further below by way of skin anaphylactic test.
1, experimental animal
Extracting waste Cavia porcellus 40, by its back lateral symmetry unhairing, area is 3cm*3cm, sub-cage rearing, observe 1d, be divided into 4 groups at random by male and female half and half, A group to the faster cream low dosage of skin infection, B group to the faster cream high dose of skin infection, C group to moist expose burn ointment contrast, D group is to positive control medicine DNF.Each group is carried out sensitization contact respectively in depilation district, both sides and contacts administration with exciting.
2, test method
With reference to the study of tcm new drug guide (pharmacy, pharmacology, toxicology) that bureau of drug administration of Ministry of Health of the People's Republic of China issues.
Sensitization contact: will by the faster cream of test product low dosage skin infection, the faster cream of high dose skin infection, moist expose burn ointment matched group, 0.1%2 by different groups, 4-dinitrofluorobenzene 0.2ml/ time, 1 times/day is applied to district of losing hair or feathers on the left of guinea pig back, and 7d and 14d respectively repeats 1 time in the same way.
Excite contact: in last to by 14d after test product sensitization, with the faster cream of low dosage skin infection, the faster cream of high dose skin infection, moist expose burn ointment, 0.1%2,4-dinitrofluorobenzene 0.2ml/ time, be applied to unhairing district on the right side of corresponding tested group of Cavia porcellus respectively, residue is washed away after contact 6h, at once observe, then observe skin again with or without skin allergy situation and systemic conditions such as redness, edema in 24h, 48h, 72h.
3, result of the test
The faster cream of table 2 skin infection is to the sensitization test (STT) (sensitization contact) of guinea pig skin
The faster cream of table 3 skin infection is to the sensitization test (STT) (exciting contact) of guinea pig skin
With reference to " standards of grading of skin allergy degree " and " hypersensitive evaluation criterion " in the study of tcm new drug guide (pharmacy, pharmacology, toxicology) that bureau of drug administration of Ministry of Health of the People's Republic of China issues, scoring statistics is carried out to protocol, the results are shown in Table 2 and table 3.Result of the test shows, compared with matched group and positive controls, the faster cream of skin infection (high dose group, low dose group) outward for guinea pig skin, without anaphylaxis.(P>0.05)
In sum, this ointment is in burn wound's treatment, be conducive to epithelialization and wound healing, extensive deep burn slough can be impelled to degenerate and to come off and toxin excretion, and can effective kill bacteria, corruption goes flesh raw, the flat skin of skin is long, blood follows enhancing, the cell that effective nutrition is impaired, improve hypoxic-ischemic and the malnutrition of local organization, alleviate cicatrix growth, make poison, rotten, the stasis of blood, empty pathology is effectively improved, local gasification is made to recover normal, make damaged tissues newborn and heal rapidly, and burn patient can be reduced lose some benefits, cut crust, the financial burden of the misery that the operations such as skin-grafting bring and great number.To trample and zoopery shows through clinical: it is fast that this ointment has sterilization reducing swelling and alleviating pain, short treating period, wound healing is fast, either shallow does not stay scar, and the degree of depth is not made skin graft, no pain of changing dressings, the magical curative effects such as wound surface and dressing do not adhere to, and without skin irritation, avirulence and skin hypersensitivity reaction, clinic application.

Claims (3)

1. treat an external application Chinese medicine ointment for sores ulceration of skin, it is characterized in that: the material used is as follows, the Radix Astragali, Radix Angelicae Sinensis, Cortex Phellodendri, Radix Scutellariae, Radix Et Rhizoma Rhei, Radix Zanthoxyli, Rhizoma Paridis, Fructus Gardeniae, the Pseudobulbus Bletillae (Rhizoma Bletillae), Radix Boehmeriae, Corium elephatis, Herba Selaginellae, Borneolum Syntheticum, Cera Flava, Oleum Brassicae campestris, stearic acid, glycerol, glyceryl monostearate, hexadecanol, potassium hydroxide, ethyl hydroxybenzoate, distilled water.
2. according to the external application Chinese medicine ointment for the treatment of sores ulceration of skin described in claim 1, it is characterized in that: Radix Astragali 450-550g, Radix Angelicae Sinensis 400-600g, Cortex Phellodendri 400-600g, Radix Scutellariae 450-550g, Radix Et Rhizoma Rhei 450-550g, Radix Zanthoxyli 350-550g, Rhizoma Paridis 400-600g, Fructus Gardeniae 480-600g, Pseudobulbus Bletillae (Rhizoma Bletillae) 450-600g, Radix Boehmeriae 450-550g, Corium elephatis 100-300g, Herba Selaginellae 400-600g, Borneolum Syntheticum 25-30g, Cera Flava 250-400g, Oleum Brassicae campestris 2000-3000g, stearic acid 450-550g, glycerol 450-550g, glyceryl monostearate 50-100g, hexadecanol 100-200g, potassium hydroxide 45-55g, ethyl hydroxybenzoate 20-30g, distilled water 3700-3800g.
3. according to the external application Chinese medicine ointment for the treatment of sores ulceration of skin described in claim 2, it is characterized in that: optimum weight proportion is as follows, Radix Astragali 500g, Radix Angelicae Sinensis 500g, Cortex Phellodendri 500g, Radix Scutellariae 500g, Radix Et Rhizoma Rhei 500g, Radix Zanthoxyli 500g, Rhizoma Paridis 500g, Fructus Gardeniae 500g, Pseudobulbus Bletillae (Rhizoma Bletillae) 500g, Radix Boehmeriae 500g, Corium elephatis 200g, Herba Selaginellae 500g, Borneolum Syntheticum 20g, Cera Flava 350g, Oleum Brassicae campestris 2500g, stearic acid 500g, glycerol 500g, glyceryl monostearate 75g, hexadecanol 150g, potassium hydroxide 50g, ethyl hydroxybenzoate 25g, distilled water 3750g.
CN201410664672.2A 2014-11-20 2014-11-20 A kind of external application Chinese medicine ointment for treating burn and scald skin ulcer Active CN104435730B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410664672.2A CN104435730B (en) 2014-11-20 2014-11-20 A kind of external application Chinese medicine ointment for treating burn and scald skin ulcer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410664672.2A CN104435730B (en) 2014-11-20 2014-11-20 A kind of external application Chinese medicine ointment for treating burn and scald skin ulcer

Publications (2)

Publication Number Publication Date
CN104435730A true CN104435730A (en) 2015-03-25
CN104435730B CN104435730B (en) 2018-03-16

Family

ID=52882991

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410664672.2A Active CN104435730B (en) 2014-11-20 2014-11-20 A kind of external application Chinese medicine ointment for treating burn and scald skin ulcer

Country Status (1)

Country Link
CN (1) CN104435730B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104873571A (en) * 2015-04-24 2015-09-02 池庆 Externally applied traditional Chinese medicine prescription for treating psoriasis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04173743A (en) * 1990-11-05 1992-06-22 Minekichi Kishi Drug for burn
CN1899518A (en) * 2006-07-13 2007-01-24 李先奇 External use Chinese medicine for treating burn and scold and its preparing method
CN102895526A (en) * 2012-10-31 2013-01-30 唐和斌 Externally-applied skin-generating oil for treatment of burn and preparation method and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04173743A (en) * 1990-11-05 1992-06-22 Minekichi Kishi Drug for burn
CN1899518A (en) * 2006-07-13 2007-01-24 李先奇 External use Chinese medicine for treating burn and scold and its preparing method
CN102895526A (en) * 2012-10-31 2013-01-30 唐和斌 Externally-applied skin-generating oil for treatment of burn and preparation method and application thereof

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
上海医药工业研究院: "《中草药临床方剂选编》", 31 March 1972, 上海人民出版社 *
周秋丽等: "《中医单方全书(珍藏本)超值版》", 30 June 2012, 天津科技翻译出版公司 *
滕彦等: "冰黄涂膜剂的制备及治疗烧伤的疗效观察", 《中国药师》 *
焦红波: "烫烧油治疗烫烧伤150例", 《中医外治杂志》 *
祝之友: "《《神农本草经》药物古今临床应用解读》", 31 January 2014, 四川科学技术出版社 *
郭国华: "《临床中药辞典》", 30 April 2007, 湖南科学技术出版社 *
颜正华: "《中药学》", 30 June 1991, 人民卫生出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104873571A (en) * 2015-04-24 2015-09-02 池庆 Externally applied traditional Chinese medicine prescription for treating psoriasis

Also Published As

Publication number Publication date
CN104435730B (en) 2018-03-16

Similar Documents

Publication Publication Date Title
CN102091203B (en) External traditional Chinese medicine preparation for treating chronic wounds and preparation method thereof
WO2017206758A1 (en) Topical pharmaceutical composition for treating multiple forms of skin wounds and manufacturing method thereof
CN102631423B (en) Care solution for wound cleaning
CN101049466B (en) Ointment of Chinese herbal medicine for treating burn and scald without pain, and scar, and preparation method
CN112245497A (en) Chinese medicinal preparation for sterilizing, diminishing inflammation and promoting wound healing and preparation method thereof
CN101837082B (en) Chinese preparation for treating burn without leaving scar
CN102357203B (en) Cortex ulmis burn ointment for curing burns
CN105362410B (en) Traditional Chinese medicine preparation for treating burns and scalds and preparation method
CN102716281B (en) Care solution for cleaning wounds after operation
CN104524522B (en) A kind of compound ointment for treating pernio
CN103721138B (en) A kind of traditional Chinese medicine for external application and its preparation method treating rosacea
CN103417781B (en) A kind of Chinese medicine for the treatment of surgical wound
CN101690760B (en) Pharmaceutical composition for treating trauma and preparation method and application of plaster thereof
CN104435730A (en) Externally applied traditional Chinese medicine ointment for treating skin ulcer
CN103142727B (en) Chinese herbal medicine composition for treating burning and scalding of human body
CN102784355B (en) First-aid drug and preparation method thereof
CN101703739B (en) Chinese medicinal linimentum for treating trauma and traumatic infection
CN105250568A (en) Medicinal composition for treating scalds and burns and preparation method thereof
CN104147315A (en) Emulsion medicine for treating scald and burn and preparation method thereof
CN102813828B (en) Stropanthus divericatus for treating external wounds
CN109893561A (en) A kind of Chinese medicine composition and preparation method thereof for treating burn and scald
CN108524734A (en) A kind of ointment for scald and preparation method thereof
CN108066466A (en) A kind of Chinese medicine composition for treating burn and scald and preparation method and application
CN102178795B (en) External medicine for treating burns and scalds and preparation method of medicine
CN107714781B (en) Pharmaceutical composition for treating burns and scalds and preparation method and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant